Showing results (841-850 of 895) with videos related to
Sort By:
Pageof 90
Global Change Biology|February 19, 2025
Host Species-Microbiome Interactions Contribute to Sphagnum Moss Growth Acclimation to WarmingTatjana Živković, Alyssa A Carrell, Gustaf Granath, et al.Gut|January 20, 2025
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolationPanagiota Maravelia, Haidong Yao, Curtis Cai, et al.Diabetes Care|November 14, 1997
Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuriaC E Mogensen, G C Viberti, E Peheim, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 18, 2008
World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registryVolker Witt, Bernd Stegmayr, Jan Ptak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLCSonia A Patel, Monique B Nilsson, Yan Yang, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 4, 2008
World apheresis registry 2003-2007 dataB Stegmayr, J Ptak, B Wikström, et al.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 7, 2020
Effect of the 2018 European drought on methane and carbon dioxide exchange of northern mire ecosystemsJ Rinne, J-P Tuovinen, L Klemedtsson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2015
KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI VandetanibMonique B Nilsson, Uma Giri, Jayanthi Gudikote, et al.The Journal of Clinical Investigation|December 9, 2025
Osimertinib activates a TGFβ2-dependent secretory program that drives lung adenocarcinoma progressionMadhurima Ghosh, Chao Wu, Abhishek Kumar, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 7, 2023
HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting StrategiesHibiki Udagawa, Monique B Nilsson, Jacqulyne P Robichaux, et al.Pageof 90